Eppen_Himac_Jan25
  Editorial
 TAKE MSMEs INTO CONFIDENCE   
 Wednesday, January 22, 2025 
 In a welcome move for thousands of small and medium pharmaceutical units spread across the country, the Union Health Ministry, on January 4 this year, had come out with a draft amendment extending the deadline for implementation of Revised Schedule M till December 31, 2025. 
  Past Editorial...  
Waters_Ebook_Dec24
TODAY'S NEWS
18:00  [IST]Rakuten Medical initiates global phase 3 trial of ASP-1929 photoimmunotherapy in combo with pembrolizumab to treat recurrent head and neck cancer
17:00  [IST]Körber appoints Oliver Weber as CEO software in the Business Area Pharma
16:00  [IST]Zerion Pharma & Aché collaborate to exploit the Dispersome technology for improvement of two marketed drug products
15:00  [IST]Larimar doses adolescents in nomlabofusp paediatric pharmacokinetic run-in study for patients with Friedreich’s ataxia
14:00  [IST]MiNK’s immune reconstitution to combat advanced gastroesophageal cancers with novel combination of Allo-iNKTs plus BOT/BAL presented at ASCO GI Symposium
13:00  [IST]Tiziana Life Sciences announces positive results from studies using nasal anti-CD3 mAb in traumatic spinal cord injury
more news >>
MedTekon_2025
TOP NEWS
08:00  [IST]NPPA seeks market-based price data on four IVs for ceiling price fixation
08:00  [IST]Pharmexcil gears up for Arab Health 2025 to strengthen India-UAE partnership in pharmaceuticals
08:00  [IST]Demand for medical gloves has seen steep rise with increasing awareness of hygiene & safety: Anindith Reddy
08:00  [IST]Workshop on Yogic Management of Respiratory Disorders held at MDNIY in New Delhi
08:00  [IST]Dentists see dentistry heading towards holistic approach, integrating comprehensive healthcare
08:00  [IST]Panel asks DoP to fix issues related to implementation of PRIP
more news >>
YESTERDAY'S NEWS
18:15  [IST]Centre abdicates its constitutional obligation, criticises patients and experts on SMA issue
18:00  [IST]Genprex starts patient dosing in phase 2 expansion portion of Acclaim-3 study of Reqorsa Gene Therapy in combo with Tecentriq to treat SCLC
17:00  [IST]Tiziana Life Sciences announces discovery of new immune biomarkers in multiple sclerosis patients treated with nasal foralumab
16:50  [IST]Syngene clinical trial subject part of pharmacokinetic study succumbs following complications
15:30  [IST]Lupin receives US FDA approval for sacubitril and valsartan tablets
14:30  [IST]IITH with NIMS unveils India’s digital pathology dataset, paves way for disease diagnosis and treatment
more news >>
INTERVIEW  
Molbio Diagnostics redefines molecular diagnostics with Truenat
Shiva Sriram, President of Molbio Diagnostics
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram